These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 30880491)

  • 21. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake.
    Luan J; Yang X; Chu L; Xi Y; Zhai G
    J Colloid Interface Sci; 2014 Aug; 428():49-56. PubMed ID: 24910034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.
    Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F
    Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.
    Nahak P; Gajbhiye RL; Karmakar G; Guha P; Roy B; Besra SE; Bikov AG; Akentiev AV; Noskov BA; Nag K; Jaisankar P; Panda AK
    Pharm Res; 2018 Aug; 35(10):198. PubMed ID: 30151753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel biomimetic nanostructured lipid carriers for cancer therapy: preparation, characterization, and
    Zhou J; Guo B; Zhu W; Sui X; Ma X; Qian J; Cao L; Han C
    Pharm Dev Technol; 2021 Jan; 26(1):81-91. PubMed ID: 33070668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
    Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW
    Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
    Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth.
    Wu P; Liu Q; Wang Q; Qian H; Yu L; Liu B; Li R
    Int J Nanomedicine; 2018; 13():5405-5418. PubMed ID: 30271137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation.
    Li M; Pei J; Ma Z; Fu J; Chen F; Du S
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):731-739. PubMed ID: 32146495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
    Wang Q; Yen YT; Xie C; Liu F; Liu Q; Wei J; Yu L; Wang L; Meng F; Li R; Liu B
    Drug Deliv; 2021 Dec; 28(1):510-519. PubMed ID: 33657950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoted Delivery of Salinomycin to Lung Cancer Through Epidermal Growth Factor Receptor Aptamers Coupled DSPE-PEG2000 Nanomicelles.
    Leng D; Hu J; Huang X; He W; Wang Y; Liu M
    J Nanosci Nanotechnol; 2018 Aug; 18(8):5242-5251. PubMed ID: 29458573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
    Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
    Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
    Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin.
    Guo S; Zhang Y; Wu Z; Zhang L; He D; Li X; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109225. PubMed ID: 31325705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Targeted killing of CD133
    Pang L; Huang X; Zhu L; Xiao H; Li M; Guan H; Gao J; Jin H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):26-35. PubMed ID: 35249867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells.
    Mao X; Liu J; Gong Z; Zhang H; Lu Y; Zou H; Yu Y; Chen Y; Sun Z; Li W; Li B; Gao J; Zhong Y
    Nanomedicine (Lond); 2015; 10(17):2677-95. PubMed ID: 26355733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.